Rani Therapeutics Holdings, Inc. has announced a research agreement with Chugai Pharmaceutical Co., Ltd. to evaluate the potential of Rani’s oral delivery technology, specifically the RaniPill®, for ...

A dissolvable drug capsule uses radiofrequency signals to ensure that people are taking their medication on schedule ...

VANCOUVER, BC and SEOUL, South Korea, March 14, 2023 /PRNewswire/ - ("NexOptic (NXO:CA)") (OTCQB: NXOPF) (FSE: E3O1) and ("IntroMedic") jointly announce that they ...

Technological developments in recent years, which include advances in image quality and improved diagnostic sensitivity, are broadening the options for diagnosing gastrointestinal (GI) conditions.

Rani Therapeutics Holdings, Inc. announced that it will present preclinical data on its RaniPill® capsule at the Endocrine Society’s Annual Meeting (ENDO 2025) in San Francisco from July 12-15, 2025.

A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual ...

What are the most exciting strides forward in GI/endoscopy technology? Ten gastroenterologists weigh in on what they think are the biggest advancements in the field. Ask a Gastroenterologist is a ...

Esophageal cancer ranks among the deadliest cancers: when diagnosed at an advanced stage, the survival rate is only about ten percent. However, if detected early, around 90 percent of patients survive ...